Table 3.
Types and examples of methodological gaps for nanotechnology-enabled health products
Type of the gap | Complete gaps | Partial gaps (material-specific) | Partial gaps (method validation) | Partial gaps (sector of applicability) |
---|---|---|---|---|
Description | No methods available | Existing standardised methods are applicable for certain types of nanomaterials only | Methods are available, but they are not standardised | Standardised methods are available in other sectors |
Examples of methodological gaps | Quantification of large API such as nucleic acids | Determination of protein corona composition | Evaluation of the interaction with the immune system | Endotoxin measurement |
API active pharmaceutical ingredient